Cardinal Health, Inc. $CAH Shares Sold by Atria Wealth Solutions Inc.

Atria Wealth Solutions Inc. decreased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 67.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,352 shares of the company’s stock after selling 38,376 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in Cardinal Health were worth $3,082,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of CAH. Wellington Management Group LLP boosted its position in Cardinal Health by 1,666.7% in the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after purchasing an additional 2,249,241 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after buying an additional 1,193,983 shares during the period. Zurich Insurance Group Ltd FI raised its stake in shares of Cardinal Health by 4,935.9% during the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after buying an additional 927,950 shares during the period. Nuveen LLC acquired a new position in shares of Cardinal Health during the 1st quarter worth approximately $106,065,000. Finally, T. Rowe Price Investment Management Inc. acquired a new position in shares of Cardinal Health during the 1st quarter worth approximately $104,951,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

NYSE CAH opened at $154.11 on Wednesday. The business has a fifty day moving average price of $151.92 and a 200 day moving average price of $151.45. Cardinal Health, Inc. has a one year low of $106.98 and a one year high of $168.44. The company has a market cap of $36.61 billion, a P/E ratio of 23.89, a P/E/G ratio of 1.30 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. During the same period in the prior year, the company earned $1.84 EPS. The firm’s revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio (DPR) is 31.63%.

Wall Street Analysts Forecast Growth

CAH has been the subject of several research analyst reports. Wells Fargo & Company reaffirmed an “overweight” rating and set a $185.00 target price (up from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Morgan Stanley reaffirmed an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Leerink Partners upped their target price on Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a research note on Monday, October 6th. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Finally, Jefferies Financial Group set a $150.00 target price on Cardinal Health in a research note on Tuesday, August 12th. Twelve investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $166.00.

Insiders Place Their Bets

In other Cardinal Health news, CEO Jason M. Hollar sold 35,901 shares of the firm’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $150.04, for a total value of $5,386,586.04. Following the completion of the sale, the chief executive officer directly owned 200,000 shares of the company’s stock, valued at $30,008,000. This trade represents a 15.22% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Michelle D. Greene sold 13,500 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the sale, the insider directly owned 14,976 shares of the company’s stock, valued at $2,228,728.32. This trade represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 271,676 shares of company stock worth $40,489,525. 0.12% of the stock is currently owned by company insiders.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.